OSRH Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

OSR Holdings Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerOSRH

Market Cap15.3M

Cash RunwayRunway < 6 months

Next Catalystn/a

Public Research Snapshot

OSR Holdings Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for VXM01 in progressive glioblastoma - final results (Phase 1) using Vaccine.

Pipeline

Asset	Indication	Modality	Stage	Public Note
Medical Device Distribution	n/a	Vaccine	n/a	Public pipeline row
DNA based Cancer Vaccine	n/a	Vaccine	n/a	Public pipeline row
VXM01	progressive glioblastoma - final results	n/a	Phase 1	Public pipeline row
Hub-and-Spoke Healthcare	n/a	n/a	n/a	Public pipeline row

Catalyst Preview

No public catalyst rows matched this view yet.

Cash Runway Preview

Estimated cash runway: Runway < 6 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
No public trial rows are loaded yet.

Scientific Context

literature_publication | Comparison of Outcomes in Elective Endovascular Aortic Repair vs Open Surgical Repair of Abdominal Aortic Aneurysms.
literature_publication | Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus.
asset_name | DNA based Cancer Vaccine
asset_name | DNA based Cancer Vaccine
asset_name | DNA based Cancer Vaccine

Want the full OSRH research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.